Bioequivalence Study on Pseudoephedrine HCl 120 mg ER Tablets Under Fasting Conditions
NCT00779831
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
DRUG:
120 mg Pseudoephedrine hydrochloride extended release tablets
Sponsor
Ranbaxy Laboratories Limited